Stryker remains a top-tier competitor in a number of attractive medical markets, including orthopedic implants, surgical instruments, endoscopy, and neurovascular devices. It enjoys a long record of innovation in its key markets, and we anticipate the pattern will continue, allowing the wide-moat company to earn attractive economic profits.
Stryker made the most of its three-year head start in placing its Mako robots in hospitals, leaving Zimmer Biomet and Johnson & Johnson to play catch-up.
Zimmer Biomet's progress with its Rosa robot could put a crimp in Stryker's robust growth in knees on its Mako robot.
|
Metric
|
SYK
|
JNJ
|
SNN
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.26 | 15.33 | 15.89 |
Price/Book Value | 6.59 | 5.40 | 2.42 |
Price/Sales | 6.08 | 4.56 | 2.28 |
Price/Cash Flow | 28.47 | 17.34 | 13.43 |
|
Metric
|
SYK
|
JNJ
|
SNN
|
|---|---|---|---|
Quick Ratio | 0.85 | 0.77 | 0.67 |
Current Ratio | 1.71 | 1.07 | 1.77 |
Interest Coverage | 12.00 | 24.45 | 2.84 |
|
Metric
|
SYK
|
JNJ
|
SNN
|
|---|---|---|---|
Return on Assets (Normalized) | 10.98% | 13.17% | 7.27% |
Return on Equity (Normalized) | 23.40% | 32.42% | 13.79% |
Return on Invested Capital (Normalized) | 14.61% | 20.93% | 9.92% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Mpxbmlwc | Vvjqlzd | $183.1 Bil | |||
| Boston Scientific Corp
BSX
| Xlsxzsh | Nrtdv | $110.1 Bil | |||
| Medtronic PLC
MDT
| Kywmlct | Dyhxnxc | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Dxtxpcts | Cgmpzb | $37.6 Bil | |||
| DexCom Inc
DXCM
| Czqcdfskgj | Lvd | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Prkjczhkq | Wnlpt | $24.1 Bil | |||
| Steris PLC
STE
| Mwbnqcyr | Ppsbcq | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Zjhxxjfwk | Bdbs | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Cvqzmttp | Yhdqc | $16.6 Bil |
:quality(80)/s3.amazonaws.com/arc-authors/morningstar/adf521c2-d9af-477d-a6bc-03ec7ca34c40.jpg)